Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
The Senate Banking Committee will hold a nomination hearing on July 11 for four key financial positions, the panel announced Thursday evening.

Brown is skeptical about new Iran sanctions legislation

News: The chair of the Senate Banking Committee doesn’t think Congress needs to pass new sanctions legislation targeting Iran.

Sen. Sherrod Brown’s (D-Ohio) committee is set to hold a hearing Thursday on how the U.S. government can better combat “networks of illicit finance and terrorism.”

But when asked about legislation targeting Iran with new sanctions, Brown doesn’t see an immediate need for Congress to act.

Much ado has been made about $6 billion in Iranian assets that were briefly unfrozen as part of a prisoner exchange with the United States only to be re-frozen after the deadly Hamas attack on Israel earlier this month.

“We’ve publicly said it should be frozen,” Brown said, referring to that $6 billion figure. But Brown added, “I don’t think we need legislation.” The Ohio Democrat said he had spoken with Biden administration officials and was “confident that it’s frozen and should stay frozen.”

As we reported Tuesday night, there’s bipartisan interest in legislation that would mandate the freeze. That includes Sen. Tim Scott (R-S.C.), the top Republican on the Senate Banking Committee, who introduced the Revoke Iranian Funding Act on Oct. 17.

But if Brown doesn’t join the effort, his committee’s jurisdiction over sanctions will make it into a bit of a chokepoint.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.